AA

Abin Abraham

Active Director Director DIN 03480779
DIN 03480779 First appointment May 2011 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2011
Shareholding value •••• Premium profile

About Abin Abraham

Data last updated:

Abin Abraham is a Director at Avani Pharma Private Limited (since 2011). The company operates in Pharma. Avani Pharma Private Limited reported revenue of ₹3.3 Lakh (FY 2019).

DIN 03480779
Primary Designation Director
Industry Pharma
First Appointment 23 May 2011
Oldest Company Age 15 yrs
Largest company Avani Pharma Private Limited · ₹3.3 Lakh (FY 2019)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Avani Pharma Private Limited U51397KA2011PTC058775
Director23 May 20112011₹3.3 Lakh (FY 2019)Active

Board colleagues of Abin Abraham

NameDINCompanyDesignation
Beny Baby03482214Avani Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Avani Pharma Private Limited
Premium access

Shareholding and investment profile for Abin Abraham

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abin Abraham

Abin Abraham currently holds 1 directorship: Avani Pharma Private Limited (Director, since 23 May 2011, revenue ₹3.3 Lakh (FY 2019)).

Abin Abraham was first appointed on 23 May 2011 as Director at Avani Pharma Private Limited.

The current boards of Abin Abraham's companies include Beny Baby (Avani Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available